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Abstract
Xanthones are a class of molecules that bind to a number of drug targets and possess a myriad of
biological properties. An understanding of xanthone biosynthesis at the genetic level should
facilitate engineering of second-generation molecules and increasing production of first-generation
compounds. The filamentous fungus Aspergillus nidulans has been found to produce two
prenylated xanthones, shamixanthone and emericellin, and we report the discovery of two more,
variecoxanthone A and epishamixanthone. Using targeted deletions that we created, we
determined that a cluster of 10 genes including a polyketide synthase gene, mdpG, is required for
prenyl xanthone biosynthesis. mdpG was shown to be required for the synthesis of the
anthraquinone emodin, monodictyphenone, and related compounds, and our data indicate that
emodin and monodictyphenone are precursors of prenyl xanthones. Isolation of intermediate
compounds from the deletion strains provided valuable clues as to the biosynthetic pathway, but
no genes accounting for the prenylations were located within the cluster. To find the genes
responsible for prenylation, we identified and deleted seven putative prenyltransferases in the A.
nidulans genome. We found that two prenyltransferase genes, distant from the cluster, were
necessary for prenyl xanthone synthesis. These genes belong to the fungal indole prenyltransferase
family that had previously been shown to be responsible for the prenylation of amino acid
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derivatives. In addition, another prenyl xanthone biosynthesis gene is proximal to one of the
prenyltransferase genes. Our data, in aggregate, allow us to propose a complete biosynthetic
pathway for the A. nidulans xanthones.
INTRODUCTION
Xanthones are polyphenolic compounds produced by higher plants, lichens, and fungi. In
common they share a 9H-xanthen-9-one scaffold, but the class is highly diverse owing to
functionalization with a range of substituents at various positions.1 As a consequence, the
xanthone core has been described as a “privileged structure,”2 with members of this group
exhibiting the potential to bind to a variety of targets. Indeed, xanthones have proven to be
an important class of secondary metabolites. Over 250 of them have been shown to possess
biological activities, including antimicrobial, antioxidant, cytotoxic, and
neuropharmacological activities.1
In many instances xanthones are functionalized with prenyl groups, commonly the five
carbon dimethylallyl moieties. Examples of prenylated xanthones include mangostanin and
γ-mangostin, which are strongly inhibitory to both sensitive and methicillin-resistant strains
of Staphylococcus aureus.3 γ-Mangostin also displays potent inhibitory activity against
mediators of prostaglandin release, COX-1 and COX-2.4 Other prenylated xanthones have
been found to be strongly active against Bacillus subtilis, Staphylococcus faecalis,
Staphylococcus typhi, and Candida glabrata.5 By themselves, prenyl groups are important
contributors to the outstanding structural diversity of natural products.6 Prenylated
secondary metabolites isolated from plants, bacteria, and fungi display a large variety of
medicinal properties, including antitumor, antiretroviral, and psychotrophic activities, that
are often distinct from their nonprenylated precursors.7
Molecular genetic analysis of the biosynthesis of prenylated and nonprenylated xanthones,
as well as prenylations in general, would greatly advance our understanding of fungal
secondary metabolite biosynthesis and, by relating gene sequence to function, facilitate
prediction of the function of homologous genes. Moreover, identification of the genes
involved in the production of particular secondary metabolites offers the possibility of
enhanced production through replacement of their native promoters with strong or inducible
promoters. In addition, semisynthesis, mutasynthesis, and chemoenzymatic synthesis that
lead to second-generation compounds with improved pharmacodynamic and
pharmacokinetic properties should greatly benefit from identification and manipulation of
the genes involved in secondary metabolite production.
The filamentous fungus Aspergillus nidulans is, in principle, an excellent organism in which
to study the biosynthesis of prenylated xanthones. It is known to produce two prenylated
xanthones, shamixanthone (2) and emericellin (3) (Figure 1).8,9 Its genome has been
sequenced and is reasonably well annotated,10,11 and development of an efficient gene
targeting system12,13 has greatly facilitated the targeted deletion of secondary metabolite
genes.14,15 We have taken advantage of these attributes to identify and characterize the
prenyl xanthone biosynthesis pathway in A. nidulans.
We previously identified, using a set of deletions of the aromatic, nonreducing PKS genes in
a chromatin remodeling mutant background, a PKS gene, mdpG, that is responsible for
synthesis of the related polyketides monodictyphenone and emodin.16,17 Here, we employed
the same set of deletions in the investigation of prenyl xanthone synthesis and found that,
again, mdpG is responsible. Deletion of genes flanking mdpG revealed that the prenylated
xanthone biosynthetic pathway is complex, involving the products of nine genes that cluster
with mdpG. Identification of intermediate compounds that accumulate in the deletion strains
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provides important clues as to the steps in the xanthone biosynthesis pathway. Many of these
intermediates have not previously been identified from A. nidulans and are of potential
medical interest. Surprisingly and interestingly, however, the prenyltransferase genes
required for prenyl xanthone biosynthesis are not clustered with the PKS gene.
Bioinformatic analysis of the A. nidulans genome allowed us to identify putative
prenyltransferase genes elsewhere in the genome whose products might be required for
prenylation of the xanthones. By deleting each of these candidate genes, we found two genes
that are required for prenylation of xanthones. They are distant from the mdpG cluster, and it
is unlikely that they could have been identified by traditional approaches. Interestingly, the
products are members of a family of prenyltransferases that are recognized to prenylate
amino acids and their derivatives, as opposed to polyketides. Lastly, we discovered a gene
proximal to one of the prenyltransferase genes that, upon deletion, leads to the loss of two of
the four prenyl xanthones that we identified. Our data, in aggregate, allowed us to unravel
the complex xanthone biosynthesis pathway in A. nidulans, and they highlight the utility of
genomics coupled with powerful molecular genetic methods for determining biosynthetic
pathways, especially when the cluster is complex and critical genes are distant from the
primary cluster.
RESULTS
Characterization of Prenylated Xanthones from A. nidulans
LO2026, an A. nidulans strain carrying a deletion of the stcJ gene (stcJΔ), which is required
for the biosynthesis of the carcinogenic secondary metabolite sterigmatocystin,18 was
cultivated on Yeast Extract Sucrose (YES) agar for 5 days at 37 °C. The rationale for the use
of an stcJΔ strain is that elimination of sterigmatocystin frees up the common polyketide
precursor malonyl-CoA and facilitates detection and isolation of other metabolites. The
strain also carries nkuAΔ to facilitate gene targeting.12 Reverse-phase LC/MS analysis of the
crude organic extract revealed the presence of several late-eluting, nonpolar metabolites
(Figure 2). For full characterization, we cultivated the strain on YES plates at a larger scale
and purified the compounds using flash chromatography, HPLC, and preparatory TLC when
necessary. NMR characterization revealed the molecules to be shamixanthone (2) and
emericellin (3), as well as, in lesser amounts, two prenylated xanthones not previously
observed from this species, variecoxanthone A (1)19 and epishamixanthone (4).20 (Figure 1;
NMR data available in the Supporting Information, Structural Characterization and Figures
S3–S15). We also found that other solid media including Yeast Agar Glucose (YAG) and
shredded wheat are conductive to xanthone production.
Analysis of Prenyl Xanthone Biogenesis through Targeted Deletions
The structural similarity of the prenyl xanthones (Figure 1) suggests a common biosynthetic
origin, and the presence of aromatic rings is indicative of formation catalyzed by a
nonreduced polyketide synthase (NR-PKS).21 Analysis of the sequenced genome of A.
nidulans suggests there are 12 NR-PKS genes in this species. The products of two of the
genes, stcA encoding the sterigmatocystin PKS and wA, a spore pigment PKS, were already
determined,22,23 leading us to focus on the 10 remaining NR-PKSs. In a previous project,
we discovered that deletion of cclA, a bre2 homologue orchestrating histone H3 lysine 4
methylation, resulted in the synthesis of related aromatic compounds including
monodictyphenone and emodin under conditions in which these molecules were normally
not observed.16 For that project we deleted the 10 annotated NR-PKS genes in a cclAΔ
background and discovered that deletion of one NR-PKS gene, AN0150.4 (using the
nomenclature of the Central Aspergillus Data Repository, CADRE,
http://www.cadre-genomes.org.uk/, and the Aspergillus genome database,
http://www.aspgd.org/) in a cclAΔ background, resulted in the elimination of these
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compounds.17 We designated AN0150.4 mdpG and the PKS it encodes MdpG. (See Table 1
for our gene designations and the corresponding annotations from CADRE/AspGD and the
Broad Institute Aspergillus Comparative Database.) For the current project we utilized the
same 10 NR-PKS deletant strains to learn whether any of them were required for the
synthesis of the prenyl xanthones in A. nidulans. We were surprised to discover that, in
addition to monodictyphenone and its related molecules, the xanthones disappeared in the
mdpGΔ strain (Figure 2) and not in the other deletant strains (data not shown). This reveals
that MdpG is the PKS responsible for the synthesis of not only emodin, monodictyphenone,
and related compounds but also the xanthones.
Next, we tried to identify additional genes involved in A. nidulans prenyl xanthone
biosynthesis. Facilitating the search, secondary metabolism genes in A. nidulans are usually
clustered, prompting us to focus on the genes surrounding mdpG (AN10039 to AN0153)
(Figure 3). To study the synthesis of the xanthones as it would occur naturally, without the
influence of a potentially powerful chromatin remodeling mutation, we deleted these genes
in the LO2026 background carrying the wild-type cclA gene (cclA+). All deletions were
verified by diagnostic PCR (using three different primer sets for each gene) (see Materials
and Methods).
Attempted deletion of AN0153, homologous to a DNA-binding protein, failed to yield any
viable transformants, in agreement with previous observations.17 This gene appears to be
essential for viability and unrelated to secondary metabolism and was thus excluded from
further study here. Deletion of the other genes significantly reduced or eliminated prenyl
xanthone formation except for AN10039, mdpEΔ, and mdpIΔ (Figures 3 and 4). Two
differences were observed in relation to our investigation using cclAΔ: In the cclAΔ
background, deletion of the transcriptional regulator gene mdpE eliminates the synthesis of
monodictyphenone and related compounds; however, for the prenyl xanthones this gene
does not appear consequential (Figure 3). Additionally, the monooxygenase gene mdpD was
not found to be important for the production of monodictyphenone and analogous products
in the cclAΔ background, whereas it plays a crucial role in prenyl xanthone formation.
The deletant strains that reduced prenyl xanthone production were examined for the
presence of any new metabolites that might represent intermediates in the biosynthetic
pathway of the xanthones. Extracts from strains carrying deletions of mdpG, mdpA, and
mdpF contained no obvious intermediates from the prenyl xanthone biosynthesis pathways.
A strain carrying a deletion of mdpH did not display new metabolites in significant amounts,
but a compound with the mass and retention time of endocrocin (10), recently identified
from an mdpH/cclA double-deletant strain,17 was observed.
The mdpLΔ strain, the extract of which displayed the greatest number of significant peaks in
the chromatogram, was grown in large scale on YES plates, and the major metabolites were
isolated by flash chromatography and HPLC and characterized primarily using NMR. The
compounds were determined to be 2,ω-dihydroxyemodin (5), ω-hydroxyemodin (6), emodin
(7), aloe-emodin (11), and chrysophanol (12) (Figure 4; NMR data shown in the Supporting
Information). Also, mdpCΔ, mdpJΔ, and mdpKΔ extracts each exhibited 5, 6, and 7, as
determined by their masses and retention times in comparison to the mdpLΔ extract, but
little or no 11 or 12. Chromatograms of mdpBΔ extracts similarly displayed the three
metabolites, along with a number of small, indistinct peaks.
The mdpDΔ extract also yielded 5, 6, and 7 but with addition of monodictyphenone (16), a
core xanthone structure (8), and the C-prenylated analog paeciloxanthone (9). Finally, the
polyketide cichorine (13) and the meroterpenoids austinol (14) and dehydroaustinol (15)
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could be detected in all strains tested, indicating they are unrelated to prenyl xanthone
biosynthesis.
Identification of Two Genes Required for Prenylation of the Xanthone Scaffold
Although our results revealed a gene cluster responsible for synthesis of A. nidulans prenyl
xanthones, the lack of a prenyltransferase gene in this cluster made it clear that the required
prenyltransferase gene(s) must be located elsewhere in the genome. On the basis of
homology to known genes of this class,24 we were able to identify several putative
prenyltransferase genes in the A. nidulans genome: AN6784.4, AN8514.4 [tdiB25],
AN10289.4, AN11080.4, AN11194.4, and AN11202.4. We deleted each of these genes, and
the deletant strains were cultured on YES plates. LC/MS analysis revealed that deletion of
AN6784.4, but not the other prenyltransferase genes, resulted in the elimination of 2–4
(Figure 5a) and accumulation of a compound which upon large-scale isolation and
characterization was confirmed to be variecoxanthone A (1). Because AN6784.4 is a
prenyltransferase gene required for synthesis of the xanthones, we hereby designate it xptA
(xanthone prenyltransferase A).
Since the A. nidulans xanthones contain two prenyl groups (except for variecoxanthone A,
which only has one), it was apparent that an additional prenyltransferase gene was required.
We hypothesized that the genome must contain an additional, unannotated prenyltransferase
gene. We performed a local BLAST search of the Broad Institute Aspergillus Comparative
Database
(http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiHome.html)
using AN6784.4 as a query sequence. We identified two annotated partial gene fragments
designated ANID_12402.1 and ANID_12430.1. Inspection of the two fragments revealed
that the 3′-end of ANID_12402.1 overlaps with the 5′-end of ANID_12430.1 by ~600 bp.
Further, the Web site predicted that the sequence of ANID_12402 is prematurely truncated
at its 3′-end. For these reasons we concluded that the nonoverlapping portion of
ANID_12430 was in fact the continuation of ANID_12402 and that the 5′-end of
ANID_12402 and the 3′-end of ANID_12430 are the boundaries of a single gene. Indeed,
the sequence of this putative gene is found intact in CADRE/AspGD but without annotation.
Deletion of this gene led to the elimination of the xanthones and accumulation of several
metabolites, including 7, 12, 16, and a putative monodictyphenone derivative (17) (Figure
5a). We designate this new gene xptB (xanthone prenyltransferase B).
Identification of an Additional Prenyl Xanthone Biosynthesis Gene
The data were suggestive of a biosynthesis in which emericellin (3) is a precursor to
shamixanthone (2) and epishamixanthone (4) (see Discussion). Even after identification of
xptA and xptB it was clear that a gene encoding the enzyme responsible for the
transformation from emericellin to shamixanthone and epishamixanthone was required but
not yet identified. Given the tendency of fungal secondary metabolite genes to exist in
clusters, we reasoned that the missing gene might reside proximate to xptA or xptB. An
analysis of the putative function of the genes neighboring xptA revealed none that were
likely involved in secondary metabolism; however, AN7998.4 and AN7999.4 upstream of
xptB were possible candidates. Deletion of AN7998.4 yielded a metabolite profile that
continued to display variecoxanthone A (1) and 3 but lacked 2 and 4 (Figure 5b and 5c),
revealing that AN7998.4 is the missing gene in the biosynthesis of the two prenyl xanthones.
We designate AN7998.4 as xptC. The amino acid sequence indicates that it is a member of
the glucose–methanol–choline (GMC) oxidoreductase superfamily, a broad class that
includes cellobiose dehydrogenase, choline dehydrogenase, and methanol oxidase.26
Deletion of AN7999.4 had no obvious effect on prenyl xanthone biosynthesis.
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We used a combination of genomics, efficient gene targeting, and natural products
chemistry to elucidate the complex prenyl xanthone biosynthesis pathway in A. nidulans, the
first such pathway to be deciphered in a fungus. This pathway is complex, involving the
products of 10 clustered genes and three genes located apart from the main cluster. The
genes mdpA through mdpL are located on the right arm of Chromosome VIII, whereas xptA
is located on the right arm of Chromosome I and xptB and xptC are found on the left arm of
Chromosome II. In all cases the genes are ~0.5 Mb from a telomere. Other uncommon
examples of separated fungal secondary metabolism genes include the genes for T-toxin
biosynthesis in Cochliobolus heterostrophus, with 9 genes in two unlinked loci, and the
nonclustered acetyl-transferase gene Tri101 involved in trichothecene biosynthesis in
Fusarium species, having a different evolutionary history from other trichothecene
genes.27,28 Without genomics and efficient gene targeting it would have been difficult, if not
impossible, to identify all of the genes in the pathway. In particular, it would have probably
been extremely difficult to identify the three genes that are separated in the genome from the
bulk of the xanthone biosynthesis genes in the absence of the ability to identify candidate
genes and to delete them en masse.
The two prenyltransferases, encoded by the xptA and xptB genes, are particularly interesting.
They are both homologous to members of a class of enzymes known as fungal indole
prenyltransferases.29 For example, XptA is 27% identical at the amino acid level to SirD
from Leptosphaeria maculans30 and 24% identical to FgaPT2 from Aspergillus fumigatus.31
XptB is 29% and 27% identical to these enzymes, respectively, and XptA and XptB are 37%
identical to each other. Unlike many other prenyltransferase enzymes, the fungal indole
prenyltransferases are soluble, lack (N/D)DxxD motifs, and continue to be active in the
absence of Mg2+.29 The fungal indole prenyltransferases are capable of regular and reverse
C-prenylations as well as N- and O-prenylations. Their solubility may be useful for
chemoenzymatic synthesis in terms of ease of manipulation and efficiency of catalysis. All
members of this class studied in detail to date prenylate compounds of amino acid origin,
whereas our data reveal that XptA and XptB clearly prenylate polyketides. There were hints
from the literature that this class might have a range of substrates extending to polyketides.
For example, the X-ray structure of dimethylallyl tryptophan synthase (DMATS) from A.
fumigatus revealed a common architecture (but no significant primary amino acid similarity)
with the bacterial enzyme NphB that catalyzes addition of a 10-carbon geranyl moiety to a
polyketide-based aromatic scaffold.32 In addition, a gene in Penicillium aethiopicum that is
homologous to indole prenyl-transferases is proximal to a polyketide gene necessary for the
formation of viridicatumtoxin and was proposed to contribute to addition of a geranyl group
to that metabolite.33 Our findings provide the first direct evidence, however, that this class
of prenyltransferases can prenylate polyketides, and the possibility must be considered that
XptA and XptB may prenylate polyketide substrates beyond those reported in this study.
Our deletions reveal the genes required for prenyl xanthone synthesis, but correlation of the
deleted genes with the intermediates that accumulate in the deletion strains allows us to
propose a biosynthetic pathway for the A. nidulans prenyl xanthones (Figure 1). We
previously detailed the synthesis of monodictyphenone (16) in a cclAΔ background, which
was dependent on many of the same secondary metabolite genes also responsible for the
prenyl xanthones.17 We propose that 16 is an intermediate en route to prenyl xanthones
(Figure 6). One new observation, however, is that from the mdpLΔ strain we have now
isolated chrysophanol (12).
Earlier work by others used isotopic precursors to propose the biosynthesis of 2 and a
similar metabolite, tajixanthone, in Aspergillus variecolor.34 The labeling patterns from
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[1-13C]- and [2-13C]-acetate incorporation suggested an octaketide precursor, which could
condense into an anthrone and possibly autooxidize to an anthraquinone. Interestingly, the
earlier work also found that isotopically labeled 12 was incorporated into tajixanthone; it
was proposed that xanthone formation proceeds from an octaketide to 7 and further to 12.
Because our earlier analysis17 indicates that 12 is not in the direct biosynthetic pathway
from 7 to 16, we propose that it is a shunt metabolite; more specifically, the mdpL knockout
may yield an unstable intermediate that transforms to chrysophanol. 7 might not be
converted to 12 when the biosynthesis is uninterrupted. An alternative explanation for
incorporation of 12 into tajixanthone is that 12 is metabolized to 7 at a low rate through an
endogenous mechanism. Aloe-emodin (11), the ω-hydroxylated analog of 12, may be a side
product arising from oxidation by an endogenous cytochrome P450 enzyme.35
Elucidating the enzymatic conversion of 7 to 16 is complicated by the fact that the process
appears to be dependent on five of the clustered genes, mdpB, mdpC, mdpJ, mdpK, and
mdpL, and that the metabolite profiles from each of the corresponding deletion strains are
similar. As a further complication, the presence of several metabolites in a deletant strain
(for example, five major compounds from mdpLΔ) makes it difficult to ascribe their roles in
the biosynthesis and their relation to each other. We refer the reader to ref 17 for a
discussion of the possible functions of mdpB, mdpC, mdpJ, mdpK, and mdpL in
monodictyphenone biosynthesis. Our data allow us, however, to deduce the remainder of the
prenyl xanthone biosynthesis pathway with considerable confidence.
In this study we show conclusively that four genes, mdpD, xptA, xptB, and xptC are, at a
minimum, responsible for conversion of monodictyphenone to the prenyl xanthones. It is
easiest to deduce the steps of the biosynthetic pathway by working back from the final
products, shamixanthone (2) and epishamixanthone (4). The xptC deletion does not
accumulate 2 or 4 but does accumulate emericellin (3) and variecoxanthone A (1). This
allows us to deduce that XptC is required for conversion of 3 or 1 to 2 and 4. The xptA
deletion strains accumulate 1 but not 3, 2, or 4. This result allows us to deduce that XptA is
required for the C-prenylation of 1 to form 3 and also allows us to deduce that 3 is the
compound that is converted by XptC to 2 and 4. Given the similarity of XptC to oxidative
enzymes, we suggest that oxidation of the primary alcohol of 3 to an aldehyde, followed by
ene cyclization,19 may yield 2 and its epimer 4. From the facts that XptA catalyzes the C-
prenylation of 1 and no prenylated xanthones are found in xptB deletion strains, we deduce
that XptB catalyzes the O-prenylation required for formation of 1 and that the O-prenylation
occurs before the C-prenylation and is a prerequisite for the C-prenylation. From the mdpD
deletant we isolated compound 8, which contains the xanthone core but does not bear
functionality at the 2 position, at which the final products feature the O-prenyl group.
Oxidation of the xanthone core at the C-2 position is necessary for O-prenylation, so we
postulate that MdpD, homologous to known monooxygenases, catalyzes oxidation prior to
O-prenylation by XptB. In the absence of the C-2 oxygen, XptA is able to yield the C-
prenylated product 9 in small amounts. In the xptB deletant strain, we were able to detect
compound 17, which we suspect to be a shunt metabolite arising from reduction of the
carbonyl group of monodictyphenone (16) and condensation with the carboxylic acid.
In addition to assisting in elucidating the biosynthetic pathway, many of the shunt products
and intermediate molecules are bioactive. For instance, 11 is cytotoxic to neuroblastoma,
Ewing sarcoma, and pPNET cell lines and inhibits neuroblastoma tumors in vivo but is not
toxic to normal cells nor animal models.36 9 displays antimicrobial and
antiacetylcholineesterase activity and is also cytotoxic against hepG2 cells.37 Compound 8
has antifungal and antibacterial activities.38 These findings indicate that a benefit of targeted
deletions of genes is the accumulation of useful quantities of biosynthetic intermediates that
may themselves possess noteworthy biological properties.
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Previous work demonstrated that a cluster of 10 genes was responsible for several related
compounds that emerged in a chromatin deletant strain of A. nidulans, including mono-
dictyphenone.17 The current work reveals that four prenyl xanthones rely on most of these
genes for their synthesis but in addition require a monooxygenase gene within the cluster
and three genes outside of the cluster, including two belonging to a family of indole
prenyltransferase genes and one homologous to GMC oxidoreductase genes. The combined
data allow us to propose that these latter genes are involved in the later stages of prenyl
xanthone formation to complete a biosynthesis in which monodictyphenone is a precursor.
MATERIALS AND METHODS
Generation of Fusion PCR Fragments, A. nidulans Protoplasting, and Transformation
All gene deletions were carried out according to the gene targeting procedures of Szewczyk
et al.13 Two ~1000 base pair fragments upstream and downstream of every targeted gene
were amplified from A. nidulans genomic DNA using PCR. Primers used in this study are
listed in Table S1, Supporting Information. The two amplified flanking sequences and an A.
fumigatus pyrG selectable marker cassette were fused together by PCR using nested primers.
A. nidulans strains in this study are displayed in Table S2, Supporting Information.
Protoplast generation and transformation were performed as described.13 The strain LO2026
carrying a deletion of the stcJ gene that eliminates sterigmatocystin production was used as
the recipient strain. Diagnostic PCR of the deletant strains was carried out using the external
primers from the first round of PCR. The difference in the size between the gene replaced by
the selective marker and the native gene allowed us to establish if the transformants carried
correct gene replacements. For further verification, diagnostic PCR was performed two more
times, using one of the external primers and a primer located inside the marker gene, then
the other external primer and an internal primer. In these instances, the deletants yielded the
PCR product of the expected size whereas no product was present in nondeletants.
Media and Cultivation of Strains
YES media was prepared by combining 20 g of yeast extract, 120 g of sucrose, 20 g of agar,
and 2 mL of trace element solution15 in 1 L H2O. For LC/MS screening, spores of LO2026
(the control strain) and three strains of each gene deletant were individually cultivated (1 ×
107 spores) on 10 × 150 mm Petri dishes containing YES agar and cultivated at 37 °C for 5
days. The agar was chopped into ~2 cm2 pieces, and the material was extracted using
sonication with methanol, followed by 1:1 methanol:dichloromethane. The organic solvents
were removed in vacuo, and the remaining material was partitioned between H2O (25 mL)
and ethyl acetate (25 mL × 2). The combined ethyl acetate layers were evaporated, and the
crude material was redissolved at a concentration of 20 mg/mL in DMSO and then diluted 5-
fold in methanol.
LC/MS Analysis
LC/MS was carried out using a ThermoFinnigan LCQ Advantage ion trap mass
spectrometer with an RP C18 column (Alltech Prevail; 2.1 × 100 mm with a 3 μm particle
size) at a flow rate of 125 μL/min and monitored by a UV detector at 254 nm. The solvent
gradient was 95% MeCN–H2O (solvent B) in 5% MeCN–H2O (solvent A) both containing
0.05% formic acid:0% B from 0 to 5 min, 0 to 100% B from 5 to 35 min, 100% B from 35
to 40 min, 100% B to 0% B from 40 to 45 min, and reequilibration with 0% B from 45 to 50
min.
Sanchez et al. Page 8














The LO2026 (stcJΔ), LO3387 (mdpLΔ), LO3337 (mdpDΔ), LO3896 (xptAΔ), and LO4178
(xptBΔ) strains were each cultivated in 25 × 150 mm Petri dishes containing 2 L YES media
and extracted in the same manner as above. The crude material was subjected to silica gel
column chromatography, using ethyl acetate and hexanes as the eluent. The materials were
further separated by preparative HPLC [Phenomenex Luna 5 μm C18 (2), 250 × 21.2 mm]
with a flow rate of 5.0 mL/min and measured by a UV detector at 250 nm. Shamixanthone
(2), emericellin (3), epishamixanthone (4), and paeciloxanthone (9) required further
purification using preparative TLC. See Supporting Information for more details about
isolation.
Structural Characterization
See the Supporting Information under Structural Characterization and Figures S3–S15.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Prenyl xanthones and compounds that emerged from the study of targeted gene deletions.
The compounds are as follows: variecoxanthone A, 1; shamixanthone, 2; emericellin, 3;
epishamixanthone, 4; 2,ω-dihydroxyemodin, 5; ω-hydroxyemodin, 6; emodin, 7; 9H-
xanthen-9-one, 8-hydroxy-1-(hydroxymethyl)-3-methyl-, 8; paeciloxanthone, 9; endocrocin,
10; aloe-emodin, 11; chrysophanol, 12; cichorine, 13; austinol, 14; dehydroaustinol, 15;
monodictyphenone, 16; and 1(3H)-isobenzofuranone, 3-(2,6-dihydroxyphenyl)-4-
hydroxy-6-methyl-, 17.
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HPLC profiles of extracts from stcJΔ; stcJΔ, cclAΔ; and stcJΔ, cclAΔ, mdpGΔ strains, as
detected by UV absorbance at 254 nm. Numbering of peaks correspond to the compounds in
Figure 1. Shamixanthone 2 and emericellin 3 elute at the same retention time.
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(Top) Organization of the genes surrounding the PKS mdpG involved in prenyl xanthone
biosynthesis. Each arrow indicates gene size and direction of transcription. On the basis of a
set of deletions we created and analyzed, genes shown in black are involved in prenyl
xanthone biosynthesis while those in gray are not. (Middle) Organization of the genes for
monodictyphenone biosynthesis in a cclAΔ background (based on ref 17). AN0147 and
AN0148 are circled to emphasize that AN0147 is unnecessary for monodictyphenone
generation but required for xanthone synthesis, whereas AN0148 is necessary for
monodictyphenone generation but not required for xanthone synthesis. (Bottom)
Organization of the genes outside of the mdpG cluster that are involved in prenyl xanthone
synthesis. The genes that were successfully deleted were AN10039 through mdpL, xptA,
xptC, AN7999, and xptB.
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HPLC extracts of strains in the cluster as detected by UV absorbance at 254 nm. ω-
Hydroxyemodin 6 and the unrelated metabolite austinol 14 elute at the same retention time.
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(a) HPLC extracts of the prenyltransferase deletant strains xptAΔ and xptBΔ as detected by
UV absorption at 254 nm. (b) HPLC extract of xptCΔ. (c) Mass spectra of the major LC/MS
peak from (top) stcJΔ control extract and (bottom) xptCΔ extract.
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Proposed biosynthetic pathway of prenyl xanthones.
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Table 1
Gene Designations of the Text and the Corresponding Annotations from Two Websitesa
gene designation putative function CADRE/AspGD annotation Broad annotation
AN10039 histidine acid phosphatase AN10039.4 unannotated
mdpA regulatory gene AN10021.4 ANID_10021.1
mdpB dehydratase AN10049.4 ANID_10049.1
mdpC ketoreductase AN0146.4 ANID_00146.1
mdpD monooxygenase AN0147.4 ANID_00147.1
mdpE regulatory gene AN0148.4 ANID_00148.1
mdpF Zn-dependent hydrolase AN0149.4 ANID_00149.1
mdpG polyketide synthase AN0150.4 ANID_00150.1
mdpH hypothetical protein AN10022.4 ANID_11847.1 + ANID_11848.1
mdpI acyl-CoA synthase AN10035.4 ANID_10035.1
mdpJ glutathione S transferase AN10038.4 ANID_10038.1
mdpK oxidoreductase AN10044.4 ANID_10044.1
mdpL Baeyer–Villiger oxidase AN10023.4 ANID_10023.1
AN0153 MYB DNA binding protein AN0153.4 ANID_00153.1
xptA prenyltransferase AN6784.4 ANID_06784.1
xptB prenyltransferase unannotated ANID_12402.1 + ANID_12430.1
xptC GMC oxidoreductase AN7998.4 ANID_07998.1
a
CADRE (http://www.cadre-genomes.org.uk) which uses the same designations as the Aspergillus genome database (AspGD,
http://www.aspgd.org) and the Broad Institute Aspergillus Comparative Database
(http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiHome.html). Putative functions are from BLAST searches performed
previously16 or for this study.
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